![[Literature Review] CRISPR/Cas9 Cellular Reporter System to Evaluate Fetal Hemoglobin Induction and T](/uploads/240820/1-240R0133944S2.png)
EDITGENE focuses on gene editing, offering highly efficient gene knock-in services using an upgraded CRISPR/Cas9 system, which provides a higher positive rate and broader applicability across gene loci
![[Literature Review] SATCAS: A CRISPR/Cas13a-based isothermal one-pot RNA detection platform](/uploads/240819/1-240Q914403A11.png)
Rapid, cost-effective, and sensitive pathogen nucleic acid detection plays a crucial role in clinical diagnosis and infection management. Traditional CRISPR/Cas13a-based detection methods show great potential in molecular diagnostics; however, most require a transcription step, an…
![[Weekly News] CRISPR-Cas9 Screening Shines: A More Sensitive and Specific Method to Identify Fetal He](/uploads/240816/1-240Q611205W57.jpg)
[Weekly News] CRISPR-Cas9 Screening Shines Again with a More Sensitive and Specific Method to Identify Fetal Hemoglobin Inducers
![[Literature Review] CRISPR-Cas12a Exhibits Metal-Dependent Specificity Switching](/uploads/allimg/240808/1-240PQ61S00-L.png)
EDITGENE offers CRISPR-based FASST detection technology and various CRISPR detection reagents. With years of technical development, we guarantee quality and prompt delivery!
